UnknownPhase 2

Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells

Belarus20 participantsStarted 2021-06-01

Plain-language summary

The trial evaluates the safety and efficacy of the olfactory mucosa-derived mesenchymal stem cells based therapy for the patients with chronic laryngeal and tracheal stenosis

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓confirmed diagnosis of chronic laryngeal or tracheal stenosis;

What they're measuring

Number of patients who didn't require the repeated surgical interventions

Timeframe: 1 year

Trial details

NCT IDNCT05535803

SponsorInstitute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2023-06-30

View on ClinicalTrials.gov More Tracheal Stenosis trials